© 2018 L.E.A.F. Pharmaceuticals LLC. All rights reserved.

L.E.A.F. Pipeline

Pipeline

L.E.A.F. Pharmaceuticals currently has several new products in development, targeting solid tumors.  Good Manufacturing Practice (GMP) campaign underway for lead products: LEAF-1401, LEAF-1701 and LEAF-1404 (generic liposomal doxorubicin).

New Products in Development